India to Pakistan: Insulin Export Trade Route
India has recorded 72 verified shipments of Insulin exported to Pakistan, representing a combined trade value of $4.5M USD. This corridor is served by 1 active Indian exporters, with an average shipment value of $63.1K USD. The leading Indian exporter is GLAND PHARMA LTD, which accounts for 100% of total export value with 72 shipments worth $4.5M USD. On the buying side, ELI LILLY PAKISTAN (PVT ) LTD is the largest importer in Pakistan with $1.7M USD in purchases. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Pakistan Insulin corridor is one of India's established pharmaceutical export routes, with 72 shipments documented worth a combined $4.5M USD. The route is dominated by GLAND PHARMA LTD, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's insulin manufacturing sector.
Across 1 active suppliers, the average shipment value stands at $63.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 75% of all shipments, consistent with insulin's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 21 days port-to-port. The route has recorded an annual growth rate of 23.7%, placing it at rank #11 among India's top insulin export destinations globally.
On the import side, key buyers of Indian insulin in Pakistan include ELI LILLY PAKISTAN (PVT ) LTD, ELI LILLY PAKISTAN (PRIVATE) LTD, ELI LILLY PAKISTAN (PVT) LTD and 3 others. ELI LILLY PAKISTAN (PVT ) LTD is the single largest importer with 25 shipments valued at $1.7M USD.
Route Characteristics
- Average transit21 days
- Peak seasonQ2
- Primary modeSea freight
- Top portHYDERABAD ICD
Market Position
- Global rank#11
- Annual growth+23.7%
- Demand growth+21.9%
- Regulatory ease77/100
Top 10 Indian Insulin Exporters to Pakistan
Showing top 10 of 1 Indian suppliers exporting Insulin to Pakistan, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | GLAND PHARMA LTD Avg $63.1K per shipment | 72 | $4.5M | 100.0% |
This table shows the top 10 of 1 Indian companies exporting insulin to Pakistan, ranked by total trade value. The listed exporters are: GLAND PHARMA LTD. GLAND PHARMA LTD is the dominant supplier with 72 shipments worth $4.5M USD, giving it a 100% market share.
Top 10 Insulin Importers in Pakistan
Showing top 10 of 6 known buyers in Pakistan receiving Insulin shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian insulin in Pakistan include ELI LILLY PAKISTAN (PVT ) LTD, ELI LILLY PAKISTAN (PRIVATE) LTD, ELI LILLY PAKISTAN (PVT) LTD, ELI LILLY PAKISTAN (PVT ) LTD,, Eli Lilly Pakistan (Pvt ) Ltd,, among 6 total buyers. The largest importer is ELI LILLY PAKISTAN (PVT ) LTD, accounting for $1.7M USD across 25 shipments — representing 37% of all insulin imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ELI LILLY PAKISTAN (PVT ) LTD | 25 | $1.7M | 36.8% |
| 2 | ELI LILLY PAKISTAN (PRIVATE) LTD | 34 | $1.6M | 34.3% |
| 3 | ELI LILLY PAKISTAN (PVT) LTD | 4 | $477.4K | 10.5% |
| 4 | ELI LILLY PAKISTAN (PVT ) LTD, | 2 | $428.4K | 9.4% |
| 5 | Eli Lilly Pakistan (Pvt ) Ltd, | 6 | $207.1K | 4.6% |
| 6 | ELI LILLY PAKISTAN PVT LTD | 1 | $203.5K | 4.5% |
Top 10 Insulin Formulations Imported by Pakistan
Showing top 10 of 12 product formulations shipped on the India to Pakistan Insulin route, ranked by trade value
Pakistan imports a wide range of insulin formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — BIPHASIC ISOPHANE INSULIN INJECTION IP,30%, SOLUBLE INSULIN AND 70% ISOPHANE INSULIN, MONOCOMPONENT HUMAN INSULIN (RECOM — accounts for $1.2M USD across 25 shipments. There are 12 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | BIPHASIC ISOPHANE INSULIN INJECTION IP,30%, SOLUBLE INSULIN AND 70% ISOPHANE INSULIN, MONOCOMPONENT HUMAN INSULIN (RECOM | 25 | $1.2M | 27.3% |
| 2 | BIPHASIC ISOPHANE INSULIN INJECTION IP,30% SOLUBLE INSULIN AND 70% ISOPHANE INSULIN,MONOCOMPONEMT HUMAN INSULIN(RECOMBI | 9 | $939.3K | 20.7% |
| 3 | Biphasic Isophane Insulin Injection IP 30% Soluble Insulin and 70% Isophane Insulin, Monocomponent Human Insulin (recomb | 4 | $628.6K | 13.8% |
| 4 | Isophane Insulin Human Suspension USP, Monocomponent Human Insulin (recombinantDNA origin) 100 USPInsulin Units/ml 10ml | 2 | $428.4K | 9.4% |
| 5 | BIPHASIC ISOPHANE INSULIN INJECTION IP,30% SOLUBLE INSULIN AND 70% ISOPHANE INSULIN, MONOCOMPONEMT HUMAN INSULIN(RECOMB | 6 | $312.7K | 6.9% |
| 6 | ISOPHANE INSULIN HUMAN SUSPENSION USP,MONOCOMPONENT HUMAN INSULIN(RECOMBINANT DNA ORIGIN) 100 USP INSULIN UNITS/ML,10ML | 6 | $214.4K | 4.7% |
| 7 | ISOPHANE INSULIN HUMAN SUSPENSION USP,MONOCOMPONENT HUMAN INSULIN(RECOMBINANT DNA ORIGIN)100 USP INSULIN UNITS/ML 10ML V | 6 | $211.8K | 4.7% |
| 8 | BIPHASIC ISOPHANE INSULIN INJECTION IP,30% SOLUBLE INSULIN&70% ISOPHANE INSULIN,MONOCOMPONEM T HUMAN INSULIN(RECOMBINAN | 6 | $207.1K | 4.6% |
| 9 | Biphasic Isophane Insulin Injection IP 30% Soluble Insulin and 70% Isophane Insulin,Monocomponent Human Insulin(recombin | 1 | $106.5K | 2.3% |
| 10 | INSULIN HUMANM INJECTION USP,MONOCOMPONENT HUMAN INSULIN (RECOMBINANT DNA ORIGIN)100IU USP INSULIN HUMAN UNITS/ML 10 ML | 3 | $103.8K | 2.3% |
Showing top 10 of 12 Insulin formulations imported by Pakistan on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 75%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
HYDERABAD ICD handles the highest volume with 52 shipments. Transit time averages 21 days by sea.
Market Dynamics
India's insulin exports to Pakistan are driven primarily by a handful of large-scale manufacturers. GLAND PHARMA LTD with 72 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 1 active exporters signals a competitive but concentrated market — buyers in Pakistan benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — GLAND PHARMA LTD — together account for 100% of total trade value on this route. The average shipment value of $63.1K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as biphasic isophane insulin injection ip,30% soluble insulin and 70% isophane insulin,monocomponemt human insulin(recombi and biphasic isophane insulin injection ip 30% soluble insulin and 70% isophane insulin, monocomponent human insulin (recomb, suggesting that buyers in Pakistan tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, ELI LILLY PAKISTAN (PVT ) LTD is the largest importer with 25 shipments worth $1.7M USD — representing 37% of all insulin imports from India on this route. A total of 6 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $4.5M
- Avg. Shipment
- $63.1K
- Suppliers
- 1
- Buyers
- 6
- Transit (Sea)
- ~21 days
- Annual Growth
- +23.7%
Other Insulin Routes
Unlock the Full India to Pakistan Insulin Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 72 shipments on this route.
Frequently Asked Questions — India to Pakistan Insulin Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Insulin to Pakistan?
The leading Indian exporters of Insulin to Pakistan are GLAND PHARMA LTD. GLAND PHARMA LTD holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Insulin exports from India to Pakistan?
India exports Insulin to Pakistan worth approximately $4.5M USD across 72 recorded shipments. The average value per shipment is $63.1K USD.
Q Which ports does India use to ship Insulin to Pakistan?
The most active port of origin is HYDERABAD ICD with 52 shipments. Indian exporters primarily use sea freight for this route, with 75% of shipments going by sea and 22% by air.
Q How long does shipping take from India to Pakistan for Insulin?
The average transit time for Insulin shipments from India to Pakistan is approximately 21 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to Pakistan Insulin trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 23.7% with demand growth tracking at 21.9%. The route is ranked #11 among India's top Insulin export destinations globally.
Q How many suppliers are active on the India to Pakistan Insulin route?
There are currently 1 active Indian suppliers exporting Insulin to Pakistan. The market is moderately concentrated with GLAND PHARMA LTD accounting for 100% of total shipment value.
Q Who are the main importers of Insulin from India in Pakistan?
The leading importers of Indian Insulin in Pakistan include ELI LILLY PAKISTAN (PVT ) LTD, ELI LILLY PAKISTAN (PRIVATE) LTD, ELI LILLY PAKISTAN (PVT) LTD, ELI LILLY PAKISTAN (PVT ) LTD,, Eli Lilly Pakistan (Pvt ) Ltd,. ELI LILLY PAKISTAN (PVT ) LTD is the largest buyer with 25 shipments worth $1.7M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Pakistan export trade corridor identified from Indian Customs (DGFT) records for Insulin.
- 2.Supplier/Buyer Matching: 1 Indian exporters and 6 importers in Pakistan matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 72 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
72 Verified Shipments
1 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists